Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Acta Neurologica Scandinavica|October 1, 1989
Blood lipid peroxides in TIA: relation to platelet function and metabolic profileF Violi, C Alessandri, A Ghiselli, et al.
Stroke|October 1, 1988
Leukocyte response in patients suffering from acute strokeF Violi, M Rasura, C Alessandri, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2009
Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approachM Rocchetti, F Del Bene, M Germani, et al.
International Journal of Molecular Sciences|April 2, 2020
Hypergravity Activates a Pro-Angiogenic Homeostatic Response by Human Capillary Endothelial CellsChiara De Cesari, Ivana Barravecchia, Olga V Pyankova, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|February 9, 2011
[Bladder malformations in a model of myelomeningocele. Preliminary report]J L Encinas, M Germani, L Burgos, et al.
Obesity Surgery|May 2, 2008
BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefitsF De Peppo, G Di Giorgio, M Germani, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|June 29, 2010
[Prenatal techniques to prevent central nervous system malformations in the surgically induced model of myelomeningocele]J L Encinas, M Germani, A Luis, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
ESMO Open|April 13, 2024
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide datasetM M Germani, G Vetere, F Santamaria, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 studyRoberto Moretto, Mirella Giordano, Anello M Poma, et al.
Pageof 3